Table 3.

Effectiveness of statin treatment at reducing LDL-C, non–HDL-C, apo B, and LDL-P.1

Reduction on therapy, %Mean on-treatment concentrationMean on-treatment percentile
ApoB studies (n = 17 035)
 LDL-C42.199.2 mg/dL21
 Non–HDL-C39.6127.0 mg/dL29
 apo B33.1101.6 mg/dL55
LDL-P Studies (n = 889)
 LDL-C35.9105.2 mg/dL27
 LDL-P30.61459 nmol/L51